GENTIAN DIAGNOSTICS

Insiders Gentian Diagnostics

Equities

GENT

NO0010748866

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-06-14 am EDT			5-day change	1st Jan Change
44 ^NOK	-2.22%		-2.22%	+6.02%

Apr. 30	Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 30	Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gentian Diagnostics Asa Resolves to Elect Ms. Hilja Ibert as Chairperson of the Board of Directors	Apr. 29	CI
Gentian Diagnostics ASA Appoints Mr. Njaal Kind as Acting CEO	Apr. 29	CI
Gentian Diagnostics ASA Announces Resignation of Hilja Ibert as CEO, Effective on April 29, 2024	Mar. 21	CI
Tomas Settevik Not to Stand for Re-Election as Chairperson of Gentian Diagnostics ASA, Effective April 29, 2024	Mar. 21	CI
Gentian Diagnostics' CEO Resigns, Wins Recommendation to Succeed Chair	Mar. 21	MT
Gentian Diagnostics Asa Announces Resignation of Frank Frantzen from the Board of Directors	Dec. 18	CI
Gentian Diagnostics ASA Announces Executive Changes, Effective from 1 January 2023	22-12-14	CI
Gentian Diagnostics ASA Announces Executive Appointments	22-05-18	CI
Gentian Diagnostics AS Announces the Resignation of Bård Sundrehagen as Executive Vice President Business Development in Gentian	19-11-07	CI
Gentian Diagnostics Announces Resignation of Johan Henrik Krefting Board	19-10-24	CI
Gentian Diagnostics Appoints Hilja Ibert as Chief Executive Officer	18-07-16	CI
Gentian Diagnostics as Appoints Njaal Kind as Group Chief Financial Officer	17-12-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer